{
    "clinical_study": {
        "@rank": "95905", 
        "arm_group": [
            {
                "arm_group_label": "no-CPAP", 
                "arm_group_type": "No Intervention", 
                "description": "CPAP vs. no-CPAP for 3 years"
            }, 
            {
                "arm_group_label": "CPAP", 
                "arm_group_type": "Active Comparator", 
                "description": "CPAP vs. no-CPAP"
            }
        ], 
        "brief_summary": {
            "textblock": "Investigators assume that continuous positive airway pressure (CPAP) therapy can reduce the\n      mortality, stroke rate and secondary coronary surgery in CAD with obstructive sleep apnea\n      (OSA) patients after percutaneous coronary intervention (PCI) or coronary artery bypass\n      grafting (CABA) during postoperative follow-up of 3 years."
        }, 
        "brief_title": "Impact of Continuous Positive Airway Pressure (CPAP) on Outcomes in Patients Undergoing Percutaneous Coronary Intervention", 
        "completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obstructive Sleep Apnea", 
            "Percutaneous Coronary Intervention"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Investigators observe whether continuous positive airway pressure (CPAP) therapy can reduce\n      the mortality, stroke rate and secondary coronary surgery in CAD with OSA patients after\n      percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABA) during\n      postoperative follow-up of 3 years. During the 3 years, we randomize all enrolled patients\n      to 2 groups separately beginning CPAP or Sham-CPAP intervention after sleep monitoring.\n      Guidance for all patients during follow-up 1 week, 2 week, 1 month, 3 month. The follow-up\n      procedure includes clinical assessments at three months, one year, two and three years\n      respectively.The primary outcome variables are prospectively being documented and are not\n      subject to observer bias.Baseline comorbidity data, results of the sleep recordings,\n      compliance with CPAP device, scores of the questionnaires as well as results of the blood\n      analysis are performed and/or documented consecutively in separate files by research\n      personnel blinded to the allocation of the study groups and/or unaware of the results of the\n      concomitant outcomes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Angiography confirmed coronary heart disease (CHD) patients\n\n          -  Underwent PCI or coronary artery bypass graft (CABG) in recent the week\n\n          -  Signed informed consent\n\n          -  Mild-to-moderate OSA\uff085\u2264AHI\u226430)\n\n        Exclusion Criteria:\n\n          -  OSA patients who has already started treatment\n\n          -  Patients presenting mainly central apnea (\u2265 50%)\n\n          -  Respiratory insufficiency patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02080156", 
            "org_study_id": "CMU-881206"
        }, 
        "intervention": {
            "arm_group_label": "CPAP", 
            "intervention_name": "CPAP", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obstructive Sleep Apnea", 
            "Percutaneous Coronary Intervention", 
            "Mortality", 
            "Biomarker", 
            "Questionnaire"
        ], 
        "lastchanged_date": "March 4, 2014", 
        "number_of_arms": "2", 
        "official_title": "Impact of CPAP on Outcomes in Patients Undergoing Percutaneous Coronary Intervention", 
        "overall_contact": {
            "email": "yuanxiandao@126.com", 
            "last_name": "Xiandao Yuan, PhD", 
            "phone": "18511821308"
        }, 
        "overall_contact_backup": {
            "email": "wuhao8812@126.com", 
            "last_name": "Hao Wu, MD", 
            "phone": "18701617082"
        }, 
        "overall_official": {
            "affiliation": "Capital Medical University Affiliated Beijing Anzhen Hospital", 
            "last_name": "Yongxiang Wei, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Mortality", 
            "safety_issue": "Yes", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02080156"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Beijing Anzhen Hospital", 
            "investigator_full_name": "Xiandao Yuan M.D.", 
            "investigator_title": "postdoctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Beijing Anzhen Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Anzhen Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}